Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin AmericaRelease Date:Research Rare Disease All Rheumatic diseases such as SLE, SS, SSc, vasculitis syndromeRelease Date:Education Inflammation & Immunology Japan Optimal treatment and management of Rheumatoid ArthritisRelease Date:Education Inflammation & Immunology Japan Education relating to Etiology, diagnosis, treatment and, management of SpondyloarthritisRelease Date:Education Inflammation & Immunology Japan Inflammation ASPIRE Rheumatology: Europe (except Germany), Israel, Turkey, Russia, Australia, New Zealand, Japan and South KoreaRelease Date:Research Inflammation & Immunology All Inflammation ASPIRE Ulcerative Colitis:Europe (except Germany), Israel, Turkey,Russia,Australia,New Zealand, Japan, South KoreaRelease Date:Research Inflammation & Immunology All Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Quality Improvement Rare Disease All Hemophilia: Improve general knowledge level of gene therapyRelease Date:Education Rare Disease Japan Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) DisordersRelease Date:Education Internal Medicine USA Serotyping of Streptococcus pneumoniaeRelease Date:Education Vaccines Japan Artificial Intelligence/Machine Learning Research in HemophiliaRelease Date:Research Rare Disease USA Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD PatientsRelease Date:Education Inflammation & Immunology Japan